Home / Neuroscience
Neuroscience
| 6 min read
With multiple trials underway and billions in investment, psychedelic therapies are moving from experimental research toward mainstream mental health care.
| 1 min read
Applications are now open for the 2026 Eppendorf & Science Prize for Neurobiology, marking the award’s 25th anniversary and recognizing exceptional early-career researchers in the field.
| 4 min read
Neuroscience discoveries, pharma investments, FOIA requests, and more led the news this week.
Discover how small molecule assemblies interact with protein aggregates to promote their breakdown in neurodegenerative diseases.
| 3 min read
By combining human-derived data with AI-driven discovery, the partnership seeks to tackle Parkinson’s disease heterogeneity and improve target selection.
| 4 min read
A new drug may restore sexual function for men for months after just three days of dosing, offering hope for those who don’t respond to existing therapies.
| 4 min read
Novel Alzheimer’s screening tests, promising weight loss drug data, an AI model linking sleep to disease risk, and more led the news this week.
| 3 min read
Novo Nordisk’s Phase 3 trials revealed that oral semaglutide failed to slow the progression of disease.
| 7 min read
While amyloid plaques form first, new work suggests targeting tau tangles that spread through the brain could also help the fight against this devastating disease.
| 10+ min read
Bioelectricity is a potent lever for controlling health. What would it look like to treat the body electrically, rather than chemically?
| 4 min read
For the first time, researchers observed new conformational states between opioid drugs binding to mu opioid receptors — findings that drug developers can use to design safer opioid drugs.
| 2 min read
Aberdeen clinical research centre widens access to clinical trials across Scotland, advancing early Alzheimer’s research
